<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31719010</article-id><article-id pub-id-type="pmc">6852449</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2019-0048</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of Using Triclosan-Impregnated Polyglactin Suture to Prevent
Infection of Saphenectomy Wounds in CABG: A Prospective, Double-Blind,
Randomized Clinical Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0568-8812</contrib-id><name><surname>Santos Filho</surname><given-names>Paulo Samuel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Marisa</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Colafranceschi</surname><given-names>Alexandre Siciliano</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD, PhD</role></contrib><contrib contrib-type="author"><name><surname>Pragana</surname><given-names>Andrea Nunes de Souza</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>RN</role></contrib><contrib contrib-type="author"><name><surname>Correia</surname><given-names>Marcelo Goulart</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MSc</role></contrib><contrib contrib-type="author"><name><surname>Sim&#x000f5;es</surname><given-names>Heloisa Helena</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>RN</role></contrib><contrib contrib-type="author"><name><surname>Rocha</surname><given-names>Fernando Alves</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Soggia</surname><given-names>Maria Eduarda de Vasconcelos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Ana Paula Malta Samuel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>RN</role></contrib><contrib contrib-type="author"><name><surname>Coutinho</surname><given-names>Annie de Azeredo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Figueira</surname><given-names>Matheus Swarovsky</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Tura</surname><given-names>Bernardo Rangel</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD, PhD</role></contrib></contrib-group><aff id="aff1">
<label>1</label>Department of Cardiovascular Surgery, Instituto Nacional de
Cardiologia (INC), Rio de Janeiro, RJ, Brazil.</aff><aff id="aff2">
<label>2</label>N&#x000fa;cleo de Avalia&#x000e7;&#x000e3;o de Tecnologia em
Sa&#x000fa;de (NATS), Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ,
Brazil.</aff><aff id="aff3">
<label>3</label>Department of Biostatistics and Bioinformatics, Instituto Nacional
de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: <bold>Paulo Samuel Santos Filho</bold>,
<ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-0568-8812">https://orcid.org/0000-0003-0568-8812</ext-link>, Rua das Laranjeiras, 374
- Laranjeiras, Rio de Janeiro, RJ, Brazil, Zip code: 22240-002. E-mail:
<email>paulosamuelsantosf@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2019</year></pub-date><volume>34</volume><issue>5</issue><fpage>588</fpage><lpage>595</lpage><history><date date-type="received"><day>06</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>10</day><month>6</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To evaluate the efficacy of triclosan-coated suture for the reduction of
infection in saphenectomy wounds of patients undergoing coronary artery
bypass graft (CABG) surgery.</p></sec><sec><title>Methods</title><p>A total of 508 patients who underwent saphenectomy in CABG surgery were
included in a prospective, randomized, double-blind trial from February/2011
to June/2014. Patients were randomized into the triclosan-coated suture
group (n= 251) and the conventional non-antibiotic suture group (n=257).
Demographic (gender and age), clinical (body mass index, diabetes, and use
of analgesics), and intraoperative (cardiopulmonary bypass and cross-clamp
times) variables and those related to the saphenectomy wound (pain,
dehiscence, erythema, infection, necrosis, and hyperthermia) were measured
and analyzed.</p></sec><sec><title>Results</title><p>Of the 508 patients who underwent saphenectomy, 69.9% were males and 40.2%
were diabetic. Thirty-three (6.5%) patients presented infection: 13 (5.3%)
with triclosan and 20 (7.9%) with conventional suture
(<italic>P</italic>=0.281). Among diabetic patients (n=204), triclosan
suture was used in 45.1% with four cases of infection; conventional suture
was used in 54.9% of them, with 11 cases of infection. Most patients (94.3%)
underwent on-pump CABG. Wound pain was observed in 9.9% of patients with
triclosan-coated suture and in 17.9% with conventional suture
(<italic>P</italic>=0.011). Wound hyperthermia was found in 1.6% of
patients with triclosan-coated suture and in 5.4% of those with conventional
suture (<italic>P</italic>=0.028).</p></sec><sec><title>Conclusion</title><p>Triclosan-coated suture shows lower infection rate in saphenectomy of
patients undergoing CABG, although the differences were not statistically
significant. Pain and wound hyperthermia were less frequent in patients with
triclosan-coated sutures compared with conventional sutures.</p></sec></abstract><kwd-group><kwd>Wound Infection</kwd><kwd>Sutures</kwd><kwd>Triclosan</kwd><kwd>Coronary Artery Bypass Graft</kwd><kwd>Cardiopulmonary Bypass</kwd><kwd>Erythema</kwd><kwd>Body Mass Index</kwd><kwd>Analgesics</kwd><kwd>Pain</kwd></kwd-group><funding-group><award-group><funding-source>Ethicon Inc.</funding-source><award-id>10-107</award-id></award-group><funding-statement>Financial support: This study was funded by Ethicon Inc.,
represented in Brazil by Johnson &#x00026; Johnson do Brasil Ind&#x000fa;stria e
Com&#x000e9;rcio de Produtos para Sa&#x000fa;de Ltda. Grant #
10-107.</funding-statement></funding-group></article-meta></front><body><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">A</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Absence</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Body mass index</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Coronary artery bypass
graft</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CONSORT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Consolidated Standards
of Reporting Trials</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CPB</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Cardiopulmonary
bypass</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">INC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Instituto Nacional de
Cardiologia</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">P</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Presence</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SIRS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Systemic inflammatory
response syndrome</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SSI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Surgical site
infection</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SUS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Sistema &#x000da;nico de
Sa&#x000fa;de</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Cardiovascular disease is the world's leading cause of mortality, morbidity, and
disability<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>. In several clinical conditions,
the coronary artery bypass graft (CABG) surgery has been effective in relieving
these patients&#x02019; symptoms and increasing survival rates<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. However, such surgery requires highly specialized
hospitals and trained staff, generating high costs for health systems. CABG is the
most practiced cardiac surgery in our country, most of which is performed by the
Sistema &#x000da;nico de Sa&#x000fa;de (SUS), the Brazilian public health system, both
in public and in philanthropic or private hospitals<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. Although CABG is the most appropriate treatment
for coronary artery disease, currently, the major challenge is to reduce
postoperative intercurrences, such as wound infections, dehiscence, and pain,
especially in the saphenectomy, presenting complications in 10% of the cases, which
can cause greater morbidity and time and cost of hospitalization<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. Although there has been an
increase in the use of arterial conduits for grafting in CABG surgery, the
saphenectomy, a technique used to obtain venous graft during operative intervention,
is one of the most performed procedures in the world<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup> and it
remains essential for obtaining the goal of complete myocardial revascularization in
most patients<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. Complications
related to the surgical technique such as hematoma, seroma, suture dehiscence,
incision border necrosis, lymphedema, pain, or infection occur in up to 30% of
patients undergoing saphenectomy<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>]</sup>. Surgical site infection (SSI) after CABG represents a high
morbidity rate, which impedes continuity of treatment and increases the length of
hospital stay and, consequently, the medical and hospital expenses<sup>[<xref rid="r11" ref-type="bibr">11</xref>-<xref rid="r15" ref-type="bibr">15</xref>]</sup>. Several risk factors for saphenectomy infection were
identified, including obesity, age over 75 years, female gender, diabetes, previous
stroke, and postoperative transfusion of five units or more of red blood
cells<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Another factor
that may influence the incidence of SSI in patients undergoing CABG is the type of
suture used in the surgical wound closure, since bacteria can adhere to the suture
material<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Sutures can
be coated with antibacterial substances that may reduce microbial load on the wound.
Triclosan (2,4,4'-trichloro-2'-hydroxydiphenyl ether) is an antibacterial substance
which, in preclinical studies, has reduced bacterial growth through the inhibition
of fatty acid synthesis<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup>.
Triclosan-coated sutures have been tested in patients undergoing saphenectomy during
CABG with divergent results<sup>[<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>.</p><p>In Brazil, despite the high number of CABG surgeries performed<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>, studies on infection in the
saphenectomy after CABG have not been found in the literature. In addition, it is
important to note that in this study all cardiac surgeries were performed by the
same team and in a teaching hospital. The aim of this study was to assess the
efficacy of triclosan-coated suture in reducing infection in the saphenectomy wounds
of CABG patients.</p></sec><sec sec-type="methods"><title>METHODS</title><p>A prospective, randomized, double-blind clinical trial studied 508 patients
undergoing saphenectomy during CABG, with and without cardiopulmonary bypass (CPB),
regardless of race. The patients were attended at the Cardiovascular Surgery Service
of the Instituto Nacional de Cardiologia (INC), Ministry of Health, Rio de
Janeiro/RJ, Brazil, between February/2011 and June/2014. This study was approved by
the INC&#x02019;s Research Ethics Committee (Protocol No. 0281/21.05.2010) and was
registered on the Registro Brasileiro de Ensaios Cl&#x000ed;nicos - ReBEC - number
RBR-4gfk87.</p><p>Patients who underwent consecutively, prospectively, and exclusively on-pump and
off-pump CABG, of both genders, and aged &#x0003e;30 years met the inclusion criteria for
the study. Patients undergoing CABG associated with other cardiac surgeries (valvar
surgeries, ventricular aneurysms, acquired ventricular septal defects, congenital
heart diseases) or undergoing vascular surgeries other than CABG; bilateral
saphenectomized patients; pregnant women; patients under antibiotic therapy for
previous infectious disease up to a month before; immunosuppressed patients
(acquired immune deficiency syndrome, neoplasia, and or use of corticosteroids &#x0003e;
0.5 mg/kg/day); patients requiring simultaneous carotid artery surgery; and patients
with severe peripheral vascular disease, history of venous disease of the deep
system and superficial thrombophlebitis of the great saphenous vein, and with
psychiatric disorder were excluded from the study.</p><p>The patients were divided into two groups according to the type of suture used to
close the saphenectomy wounds: triclosan-coated 910 polyglactin suture
(Vicryl&#x000ae; Plus) (n=251) and conventional 910 polyglactin suture
(Vicryl&#x000ae;) (n=257), both from the same manufacturer.</p><p>We performed preoperative decolonization with a chlorhexidine bath one hour before
going to the surgical center and using nasal Mupirocine twice a day during the five
days before surgery. Trichotomy was done with electric tricotomizer only in the
incision site, in the operating room, and asepsis was done with soap chlorhexidine
followed by alcoholic chlorhexidine. The surgical incision was made between 30 and
60 minutes after the infusion of antibiotic prophylaxis according to the routine of
the INC&#x02019;s Comiss&#x000e3;o de Controle de Infec&#x000e7;&#x000e3;o Hospitalar, the
hospital&#x02019;s infection control commission. We closed all saphenectomies with Vicryl
and Vicryl Plus sutures, in three levels in the thighs and in two levels in the
legs.</p><p>At randomization, a table was generated using a specific computational routine. The
cardiovascular surgeon did not have prior access to the table (allocation was
concealed). A blocked randomization scheme was used, with block sizes of 2, 4, or 6.
This table remained blinded to all participants in the surgical procedure, as well
as to all those who were involved in its follow-up, except for the professionals
responsible for randomization and masking. In the masking process, counselors, the
nurses responsible for the randomization, the secretary, and surgical technologists
learned about the drawn sutures/patients. Surgeons, the researchers and their
assistants, and the patients were masked.</p><p>Patient data were obtained from control charts, including demographic (gender and
age), clinical (body mass index, diabetes, and analgesic use), and intraoperative
(CPB and cross-clamp times) variables and those related to the saphenectomy wounds
(pain, dehiscence, erythema, infection, necrosis, and hyperthermia).</p><p><xref ref-type="fig" rid="f1">Figure 1</xref> shows that in the follow-up 38 patients
were excluded from the intervention group (26 patients didn&#x02019;t show up to at least
two appointments and 12 died) and 37 patients were excluded from the control group
(26 patients didn&#x02019;t show up to at least two appointments and 11 died).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>CONSORT flowchart shows the total amount of included and excluded
patients, and how many sat in each phase of the essay.
CONSORT=Consolidated Standards of Reporting Trials</p></caption><graphic xlink:href="rbccv-34-05-0588-g01"/></fig>
</p><p>The sutures were evaluated and photographed around the 7<sup>th</sup>,
14<sup>th</sup>, and 30<sup>th</sup> day of saphenectomy. Saphenectomy wound
infection was defined as hyperemia and peri-border cellulitis with opening
(dehiscence or necrosis) of 3 cm or more in the longitudinal direction and drainage
of purulent secretion within 30 days of the surgical procedure. Wound pain and
hyperthermia were evaluated three times during 30 days after saphenectomy
considering the scale 0 = absence, 1 = mild, 2 = moderate, and 3 = severe for pain,
and cold, normal, and warm for temperature.</p><sec><title>Statistical Analysis</title><p>Descriptive statistics were used to characterize the sample. Continuous variables
were expressed as mean &#x000b1; standard deviation and compared using unpaired
Student&#x02019;s <italic>t</italic>-test. Categorical variables were expressed as
absolute and relative frequency (%) and compared using the Chi-square test.
Differences in the distribution of numerical variables between groups were
analyzed by Student&#x02019;s <italic>t</italic>-test and Mann-Whitney U test. The
differences between categorical variables were analyzed using Chi-square and
Fisher's exact tests. All analyses were performed using the R software
(<italic>The R Foundation for Statistical Computing</italic>, Vienna,
Austria), version 3.3.3<sup>[<xref rid="r20" ref-type="bibr">20</xref>]</sup>.
The level of significance was <italic>P</italic> &#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Of the 508 patients studied, 69.9% were males and 30.1% were females, with a mean age
of 61.1 &#x000b1; 9.3 years (range 36-84 years). Results of clinical variables
related to saphenectomy and intraoperative wounds are described in <xref rid="t1" ref-type="table">Table 1</xref>. The most frequent findings included
erythema (26.5%) and necrosis (23.6%).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Clinical profile of 508 patients undergoing saphenectomy during CABG.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="33%" span="1"/><col width="33%" span="1"/><col width="33%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Variables</th><th align="center" rowspan="1" colspan="1">N (%)</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">204 (40.2)</td></tr><tr><td align="left" rowspan="4" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">Malnutrition</td><td align="center" rowspan="1" colspan="1">2 (0.4)</td></tr><tr><td align="left" rowspan="1" colspan="1">Eutrophic</td><td align="center" rowspan="1" colspan="1">173 (36.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Borderline</td><td align="center" rowspan="1" colspan="1">163 (34.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Obesity</td><td align="center" rowspan="1" colspan="1">135 (28.5)</td></tr><tr><td align="left" colspan="2" rowspan="1">Wound pain</td><td align="center" rowspan="1" colspan="1">71 (13.9)</td></tr><tr><td align="left" colspan="2" rowspan="1">Dehiscence</td><td align="center" rowspan="1" colspan="1">117 (22.9)</td></tr><tr><td align="left" colspan="2" rowspan="1">Erythema</td><td align="center" rowspan="1" colspan="1">133 (26.5)</td></tr><tr><td align="left" colspan="2" rowspan="1">Infection</td><td align="center" rowspan="1" colspan="1">33 (6.6)</td></tr><tr><td align="left" rowspan="2" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">153 (30.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">355 (69.9)</td></tr><tr><td align="left" colspan="2" rowspan="1">Necrosis</td><td align="center" rowspan="1" colspan="1">118 (23.6)</td></tr><tr><td align="left" colspan="2" rowspan="1">Wound hyperthermia</td><td align="center" rowspan="1" colspan="1">18 (3.5)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>BMI=body mass index; CABG=coronary artery bypass graft</p></fn></table-wrap-foot></table-wrap><p>Results of comparative analysis between groups of patients undergoing saphenectomy
with triclosan-coated suture and conventional suture are shown in <xref rid="t2" ref-type="table">Table 2</xref>. There were differences between the
groups for the variables pain (<italic>P</italic>=0.011) and wound hyperthermia
(<italic>P</italic>=0.028), which were significantly more frequent in the
conventional group than in the triclosan-coated suture group.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Results of statistical analysis of groups of patients undergoing saphenectomy
with triclosan-coated suture (n = 251) and conventional suture (n =
257).</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Triclosan</th><th align="center" rowspan="1" colspan="1">Conventional</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Gender</td><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">76 (30.3)</td><td align="center" rowspan="1" colspan="1">77 (30.0)</td><td align="center" rowspan="2" colspan="1">1.000</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">175 (69.7)</td><td align="center" rowspan="1" colspan="1">180 (70.0)</td></tr><tr><td align="left" rowspan="4" colspan="1">BMI (kg/m<sup>2</sup>)</td><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">&#x0003c; 18</td><td align="center" rowspan="1" colspan="1">1 (0.4)</td><td align="center" rowspan="1" colspan="1">1 (0.4)</td><td align="center" rowspan="4" colspan="1">0.866</td></tr><tr><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">18 - 25</td><td align="center" rowspan="1" colspan="1">88 (38.3)</td><td align="center" rowspan="1" colspan="1">84 (34.9)</td></tr><tr><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">26 - 30</td><td align="center" rowspan="1" colspan="1">78 (33.9)</td><td align="center" rowspan="1" colspan="1">85 (35.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e; 30</td><td align="center" rowspan="1" colspan="1">63 (27.4)</td><td align="center" rowspan="1" colspan="1">71 (29.5)</td></tr><tr><td align="left" rowspan="2" colspan="1">Diabetes</td><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">92 (36.7)</td><td align="center" rowspan="1" colspan="1">112 (43.6)</td><td align="center" rowspan="2" colspan="1">0.124</td></tr><tr><td align="left" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">159 (63.3)</td><td align="center" rowspan="1" colspan="1">145 (56.4)</td></tr><tr><td align="left" rowspan="2" colspan="1">Wound pain</td><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">25 (10.0)</td><td align="center" rowspan="1" colspan="1">46 (17.9)</td><td align="center" rowspan="2" colspan="1">0.011</td></tr><tr><td align="left" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">226 (90.0)</td><td align="center" rowspan="1" colspan="1">211 (82.1)</td></tr><tr><td align="left" rowspan="2" colspan="1">Wound hyperthermia</td><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">4 (1.6)</td><td align="center" rowspan="1" colspan="1">14 (5.4)</td><td align="center" rowspan="2" colspan="1">0.028</td></tr><tr><td align="left" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">247 (98.4)</td><td align="center" rowspan="1" colspan="1">243 (94.6)</td></tr><tr><td align="left" rowspan="2" colspan="1">Infection</td><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">13 (5.3)</td><td align="center" rowspan="1" colspan="1">20 (7.9)</td><td align="center" rowspan="2" colspan="1">0.281</td></tr><tr><td align="left" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">238 (94.7)</td><td align="center" rowspan="1" colspan="1">237 (92.1)</td></tr><tr><td align="left" rowspan="2" colspan="1">CPB</td><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">238 (94.8)</td><td align="center" rowspan="1" colspan="1">241 (93.8)</td><td align="center" rowspan="2" colspan="1">0.703</td></tr><tr><td align="left" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">13 (5.2)</td><td align="center" rowspan="1" colspan="1">16 (6.2)</td></tr><tr><td align="left" colspan="2" rowspan="3">Age (years)</td><td style="border-bottom:hidden" align="center" rowspan="1" colspan="1">62.01 (8.62)</td><td style="border-bottom:hidden" align="center" rowspan="1" colspan="1">60.39 (9.03)</td><td align="center" rowspan="3" colspan="1">0.024</td></tr><tr><td style="border-bottom:hidden" align="center" rowspan="1" colspan="1">[60.91-63.11]</td><td style="border-bottom:hidden" align="center" rowspan="1" colspan="1">[58.95-61.35]</td></tr><tr><td align="center" rowspan="1" colspan="1">[38-83]</td><td align="center" rowspan="1" colspan="1">[36-84]</td></tr><tr><td align="left" rowspan="2" colspan="1">Times (min)</td><td style="border-bottom:hidden" align="left" rowspan="1" colspan="1">CPB</td><td align="center" rowspan="1" colspan="1">87 [75.0-105.0]</td><td align="center" rowspan="1" colspan="1">90 [77.5-110.0]</td><td align="center" rowspan="1" colspan="1">0.187</td></tr><tr><td align="left" rowspan="1" colspan="1">Cross-clamp</td><td align="center" rowspan="1" colspan="1">75.00 [60.3-91.0]</td><td align="center" rowspan="1" colspan="1">76 [65.0-98.5]</td><td align="center" rowspan="1" colspan="1">0.158</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>Mean &#x000b1; standard deviation, median and variance, or number (%)</p><p>A=absence; BMI=body mass index; CPB=cardiopulmonary bypass;
P=presence</p></fn></table-wrap-foot></table-wrap><p>Among the patients undergoing saphenectomy, 33 (6.5%) presented infection (<xref ref-type="fig" rid="f2">Figures 2</xref> and <xref ref-type="fig" rid="f3">3</xref>), being 13 (39.4%) in the triclosan group and 20 (60.6%) in the
conventional group (<italic>P</italic>=0.281) (<xref rid="t3" ref-type="table">Table
3</xref>). The <xref ref-type="fig" rid="f4">Figures 4</xref> and <xref ref-type="fig" rid="f5">5</xref> show saphenectomy sutures without infection.
Among diabetic patients (n=204), triclosan was used in 45.1% of them, with four
cases of infection, and conventional suture was used in 54.9%, with 11 cases of
infection (<italic>P</italic>=0.284). There was a significant difference for the
wound pain variable, which was observed in 9.9% of patients sutured with triclosan
and in 17.9% with conventional suture (<italic>P</italic>=0.009)<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. Wound hyperthermia was recorded
in 50% of the patients with infection in the conventional group and in 15.4% of
those in the triclosan-coated suture group (<italic>P</italic>=0.067).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Photograph showing infection in a patient undergoing saphenectomy with
Vicryl suture during coronary artery bypass graft.</p></caption><graphic xlink:href="rbccv-34-05-0588-g02"/></fig>
</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Photograph showing infection in a patient undergoing saphenectomy with
Vicryl Plus suture.</p></caption><graphic xlink:href="rbccv-34-05-0588-g03"/></fig>
</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Results of statistical analysis of groups of patients with infection (n=33)
undergoing saphenectomy with triclosan-coated suture and conventional
suture.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Triclosan (n = 13)</th><th align="center" rowspan="1" colspan="1">Conventional (n = 20)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">7 (53.8)</td><td align="center" rowspan="1" colspan="1">8 (40.0)</td><td align="center" rowspan="2" colspan="1">0.4930</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">6 (46.2)</td><td align="center" rowspan="1" colspan="1">12 (60.0)</td></tr><tr><td align="left" rowspan="4" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">&#x0003c; 18</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="1" colspan="1">0 (0.0)</td><td align="center" rowspan="4" colspan="1">0.805</td></tr><tr><td align="left" rowspan="1" colspan="1">18 - 25</td><td align="center" rowspan="1" colspan="1">4 (33.3)</td><td align="center" rowspan="1" colspan="1">7 (38.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">26 - 30</td><td align="center" rowspan="1" colspan="1">5 (41.7)</td><td align="center" rowspan="1" colspan="1">5 (27.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x0003e; 30</td><td align="center" rowspan="1" colspan="1">3 (25.0)</td><td align="center" rowspan="1" colspan="1">6 (33.3)</td></tr><tr><td align="left" rowspan="2" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">4 (30.8)</td><td align="center" rowspan="1" colspan="1">11 (55.0)</td><td align="center" rowspan="2" colspan="1">0.284</td></tr><tr><td align="left" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">9 (69.2)</td><td align="center" rowspan="1" colspan="1">9 (45.0)</td></tr><tr><td align="left" rowspan="2" colspan="1">Wound pain</td><td align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">5 (38.5)</td><td align="center" rowspan="1" colspan="1">17 (85.0)</td><td align="center" rowspan="2" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">8 (61.5)</td><td align="center" rowspan="1" colspan="1">3 (15.0)</td></tr><tr><td align="left" rowspan="2" colspan="1">Wound hyperthermia</td><td align="left" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">2 (15.4)</td><td align="center" rowspan="1" colspan="1">10 (50.0)</td><td align="center" rowspan="2" colspan="1">0.067</td></tr><tr><td align="left" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">11 (84.6)</td><td align="center" rowspan="1" colspan="1">10 (50.0)</td></tr><tr><td align="left" colspan="2" rowspan="3">Age (years)</td><td align="center" rowspan="1" colspan="1">62.69 (10.80)</td><td align="center" rowspan="1" colspan="1">60.40 (7.98)</td><td align="center" rowspan="3" colspan="1">0.488</td></tr><tr><td align="center" rowspan="1" colspan="1">[56.79-68.59]</td><td align="center" rowspan="1" colspan="1">[56.90-63.90]</td></tr><tr><td align="center" rowspan="1" colspan="1">[44-78]</td><td align="center" rowspan="1" colspan="1">[47-73]</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>Mean &#x000b1; standard deviation, median and variance, or number (%)</p><p>A=absence; BMI=body mass index; P=presence</p></fn></table-wrap-foot></table-wrap><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Absence of infection in a patient undergoing saphenectomy with Vicryl
suture.</p></caption><graphic xlink:href="rbccv-34-05-0588-g04"/></fig>
</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Absence of infection in a patient with Vicryl Plus suture.</p></caption><graphic xlink:href="rbccv-34-05-0588-g05"/></fig>
</p><p>The majority of the patients (94.3%) underwent saphenectomy during on-pump CABG. The
analysis of CPB and cross-clamp times showed no significant difference between the
triclosan and conventional groups (<xref rid="t4" ref-type="table">Table
4</xref>).</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Results of statistical analysis of cardiopulmonary bypass (CPB) and
cross-clamp times of groups of patients with infection (n=33) undergoing
saphenectomy with triclosan-coated suture and conventional suture.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/><col width="16%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Patients</th><th align="center" rowspan="1" colspan="1">CPB time (min)</th><th align="center" rowspan="1" colspan="1">P-value</th><th align="center" rowspan="1" colspan="1">Cross-clamp time (min)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Triclosan</td><td align="left" rowspan="1" colspan="1">Infected</td><td align="center" rowspan="1" colspan="1">105 [90.8-136.3]</td><td align="center" rowspan="2" colspan="1">0.0774</td><td align="center" rowspan="1" colspan="1">97.5 [74.8-126.3]</td><td align="center" rowspan="2" colspan="1">0.0544</td></tr><tr><td align="left" rowspan="1" colspan="1">Non-infected</td><td align="center" rowspan="1" colspan="1">88.0 [77.0-110.0]</td><td align="center" rowspan="1" colspan="1">76.0 [65.0-97.5]</td></tr><tr><td align="left" rowspan="2" colspan="1">Conventional</td><td align="left" rowspan="1" colspan="1">Infected</td><td align="center" rowspan="1" colspan="1">85.0 [73.0-104.3]</td><td align="center" rowspan="2" colspan="1">0.959</td><td align="center" rowspan="1" colspan="1">69.5 [57.5-80.3]</td><td align="center" rowspan="2" colspan="1">0.342</td></tr><tr><td align="left" rowspan="1" colspan="1">Non-infected</td><td align="center" rowspan="1" colspan="1">86.0 [73.0-104.8]</td><td align="center" rowspan="1" colspan="1">75.0 [60.0-91.8]</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The results of this study show that the triclosan-coated suture presented the lowest
rate of infection in saphenectomy of patients undergoing CABG. Pain and hyperthermia
in the saphenectomy wound were less frequent in patients sutured with triclosan
compared to those sutured with conventional suture.</p><p>In this study, considering 508 patients, the saphenectomy infection rate was 6.5%.
This result is in agreement with previous studies, whose infection rates vary from 2
to 20%<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. Triclosan-coated
sutures have been tested on saphenectomy with controversial results.
Thimour-Bergstrom et al.<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>,
investigating triclosan-coated or non-coated sutures to close the saphenectomy
wounds of 374 CABG patients, found out that there was a reduction in the infection
rate in patients with triclosan sutures in 30-day (clinical visit) and 60-day
(telephone interview) follow-ups. In a prospective randomized study about triclosan
use in saphenectomy infection with 323 patients undergoing CABG, Seim et
al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup> did not find
beneficial effects of this antibacterial in the prevention of infection when
compared to the conventional suture in a 30-day follow-up.</p><p>By analyzing the infection rate of the two interventions, we observed a reduction in
the risk of infection of 33.4% (5.3% <italic>vs</italic>. 7.9% in the triclosan and
conventional groups, respectively) in the saphenectomy. This risk reduction cannot
be explained by any clinical differences between the two groups and taking into
account the results of other articles, we should consider that it is associated with
the use of triclosan-impregnated suture. Although it did not reach statistically
significance, probably because the infection rate in saphenectomy was lower than
expected, the result has clinical value because the use of this suture would avoid
infection in every 39 patients.</p><p>Regarding variables related to saphenectomy wounds, there was a significant
difference between the groups for pain and wound hyperthermia, which were less
frequent in the triclosan group. However, in the comparison between patients with
infection undergoing saphenectomy with triclosan-coated suture and conventional
suture, only pain was statistically significant, being less frequent with triclosan
suture. This result may be due to the reduced casuistic size.</p><p>Most patients underwent saphenectomy during on-pump CABG. The analysis of CPB and
cross-clamp times in patients with and without infection showed no significant
difference between the triclosan and conventional groups. According to Santos et
al.<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>, the relative
possibility of death in CABG surgery is 209% higher when the CPB time is greater
than 115 minutes. In this study, mean CPB time was 108.6 minutes. One of the most
serious problems related to CPB is the systemic inflammatory response syndrome
(SIRS), characterized by clinical alterations in ventricular, pulmonary, and renal
functions, coagulation disorders, susceptibility to infections, altered vascular
permeability and accumulation of fluid in the interstitium, leukocytosis,
vasoconstriction, and hemolysis<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>. Despite these changes, the body&#x02019;s ability to reverse this
condition and the use of corticosteroids may reduce the morbidity and mortality
rates<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p><p>Researchers have analyzed predictors of infection in patients undergoing CABG. Risk
factors identified include aging, female gender, obesity, diabetes, and preoperative
levels of hemoglobin<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>. In this study, diabetes was registered in 40.2% of the
patients. However, a significant association between diabetes and infection in both
groups was not found.</p><p>Although a systematic review with recent meta-analysis has found in 21 clinical
trials moderate quality of evidence that triclosan-coated sutures are effective in
reducing SSI<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>, it should be
noted that infection in saphenectomy wounds in patients undergoing on-pump and
off-pump CABG requires more scientific research.</p><p>The reduction of infection in the saphenectomy after CABG is fundamental for both the
patient (discomfort and pain) and the hospital institution (increased
hospitalization time and costs, more procedures and medication use), since this
knowledge can subsidize interventions aiming at the planning and execution of new
preventive strategies, minimizing the complications associated with this surgery and
reducing hospital costs. This information can also be used as an indicator of
quality of care in the postoperative period, in this case provided by SUS. In
addition, studies on sutures coated with antibacterial substances compared to
uncoated sutures in reducing SSI may contribute to the development of guidelines for
the prevention of such infections<sup>[<xref rid="r27" ref-type="bibr">27</xref>]</sup>.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>In patients undergoing saphenectomy during CABG, the most frequent variables, such as
demographic, clinical, and those related to saphenectomy wounds, were male gender,
diabetes, erythema, and necrosis. Pain and hyperthermia in the wound were less
frequent in patients sutured with triclosan. The patients with triclosan-coated
sutures presented smaller infection rate in saphenectomy than those with non-coated
sutures undergoing CABG, although the differences were not statistically
significant.</p><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Author's roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">PSSF</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MS</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; interpretation of data for the
work; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ASC</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception of the work; interpretation of data for the work; final
approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ANSP</td><td align="left" valign="top" rowspan="1" colspan="1">The acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MGC</td><td align="left" valign="top" rowspan="1" colspan="1">Collaborated in the article performing the
Statistical Analysis and participating in its writing; final
approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HHS</td><td align="left" valign="top" rowspan="1" colspan="1">The acquisition of data for the work;
final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FAR</td><td align="left" valign="top" rowspan="1" colspan="1">The acquisition, analysis of data for the
work; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MEVS</td><td align="left" valign="top" rowspan="1" colspan="1">The acquisition, analysis of data for the
work; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APMSS</td><td align="left" valign="top" rowspan="1" colspan="1">The acquisition of data for the work;
final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AAC</td><td align="left" valign="top" rowspan="1" colspan="1">The acquisition, analysis of data for the
work; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MSF</td><td align="left" valign="top" rowspan="1" colspan="1">The acquisition, analysis of data for the
work; final approval of the version to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BRT</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Coordena&#x000e7;&#x000e3;o de Ensino e Pesquisa,
Instituto Nacional de Cardiologia (INC), Rio de Janeiro, RJ, Brazil.</p></fn><fn fn-type="financial-disclosure"><p>Financial support: This study was funded by Ethicon Inc., represented in Brazil
by Johnson &#x00026; Johnson do Brasil Ind&#x000fa;stria e Com&#x000e9;rcio de
Produtos para Sa&#x000fa;de Ltda. Grant # 10-107.</p></fn><fn fn-type="COI-statement"><p>Conflict of interest: Sources of Funding. Research reported in this publication
was financially supported by Ethicon Inc., represented in Brazil by Johnson
&#x00026; Johnson do Brasil Ind&#x000fa;stria e Com&#x000e9;rcio de Produtos para
Sa&#x000fa;de Ltda. (grant # 10-107). The grant comprised sutures donation,
monetary funding to support data collection, and publication activities. The
funders of the study had no role in study design, data collection, data
analysis, data interpretation, or writing of the report.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Gara</surname><given-names>PT</given-names></name><name><surname>Kushner</surname><given-names>FG</given-names></name><name><surname>Ascheim</surname><given-names>DD</given-names></name><name><surname>Casey</surname><given-names>DE Jr</given-names></name><name><surname>Chung</surname><given-names>MK</given-names></name><name><surname>de Lemos</surname><given-names>JA</given-names></name><etal/></person-group><article-title>2013 ACCF/AHA guideline for the management of ST-elevation
myocardial infarction: a report of the American college of cardiology
foundation/American heart association task force on practice
guidelines</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>61</volume><issue>4</issue><fpage>e78</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2012.11.019</pub-id><pub-id pub-id-type="pmid">23256914</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Global Health Observatory (GHO) data</source><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name><year>c2016</year><date-in-citation content-type="access-date">2019 Ago 23</date-in-citation><comment>Available from <ext-link ext-link-type="uri" xlink:href="http://www.who.int/gho/mortality_burden_disease/en/">http://www.who.int/gho/mortality_burden_disease/en/</ext-link></comment></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Authors/Task Force members</collab><name><surname>Windecker</surname><given-names>S</given-names></name><name><surname>Kolh</surname><given-names>P</given-names></name><name><surname>Alfonso</surname><given-names>F</given-names></name><name><surname>Collet</surname><given-names>JP</given-names></name><name><surname>Cremer</surname><given-names>J</given-names></name><etal/></person-group><article-title>2014 ESC/EACTS guidelines on myocardial revascularization: the
task force on myocardial revascularization of the European society of
cardiology (ESC) and the European association for cardio-thoracic surgery
(EACTS) developed with the special contribution of the European association
of percutaneous cardiovascular interventions (EAPCI)</article-title><source>Eur Heart J</source><year>2014</year><volume>35</volume><issue>37</issue><fpage>2541</fpage><lpage>2619</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehu278</pub-id><pub-id pub-id-type="pmid">25173339</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piegas</surname><given-names>LS</given-names></name><name><surname>Bittar</surname><given-names>OJ</given-names></name><name><surname>Haddad</surname><given-names>N</given-names></name></person-group><article-title>Myocardial revascularization surgery (MRS): results from national
health system (SUS)</article-title><source>Arq Bras Cardiol</source><year>2009</year><volume>93</volume><issue>5</issue><fpage>555</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1590/s0066-782x2009001100018</pub-id><comment>Erratum in: Arq Bras Cardiol. 2010;95(2):279.</comment><pub-id pub-id-type="pmid">20084319</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Barros Ara&#x000fa;jo J&#x000fa;nior</surname><given-names>R</given-names></name><name><surname>Gonzaga</surname><given-names>ICA</given-names></name><name><surname>Fernandes</surname><given-names>GA</given-names></name><name><surname>Lima</surname><given-names>ACG</given-names></name><name><surname>Cortelazzi</surname><given-names>PST</given-names></name><name><surname>de Oliveira</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Low-intensity LED therapy (&#x003bb; 640 &#x000b1; 20 nm) on
saphenectomy healing in patients who underwent coronary artery bypass graft:
a randomized, double-blind study</article-title><source>Lasers Med Sci</source><year>2018</year><volume>33</volume><issue>1</issue><fpage>103</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1007/s10103-017-2354-z</pub-id><pub-id pub-id-type="pmid">29027034</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athanasiou</surname><given-names>T</given-names></name><name><surname>Aziz</surname><given-names>O</given-names></name><name><surname>Skapinakis</surname><given-names>P</given-names></name><name><surname>Perunovic</surname><given-names>B</given-names></name><name><surname>Hart</surname><given-names>J</given-names></name><name><surname>Casula</surname><given-names>R</given-names></name><etal/></person-group><article-title>Leg wound infection after coronary artery bypass grafting: a
meta-analysis comparing minimally invasive versus conventional vein
harvesting</article-title><source>Ann Thorac Surg</source><year>2003</year><volume>76</volume><issue>6</issue><fpage>2141</fpage><lpage>2146</lpage><pub-id pub-id-type="doi">10.1016/s0003-4975(03)01435-8</pub-id><pub-id pub-id-type="pmid">14667670</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gontijo de Deus</surname><given-names>K</given-names></name><name><surname>Diogo Filho</surname><given-names>A</given-names></name><name><surname>Cesar Santos</surname><given-names>P</given-names></name></person-group><article-title>A randomized controlled trial of mini incision or conventional
incision for saphenous vein harvesting in patients undergoing myocardial
revascularization</article-title><source>Ann Med Surg (Lond)</source><year>2016</year><volume>7</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.amsu.2016.02.013</pub-id><pub-id pub-id-type="pmid">27006766</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>DS</given-names></name><name><surname>Gomes</surname><given-names>WJ</given-names></name></person-group><article-title>The future of saphenous vein graft for coronary
artery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2008</year><volume>23</volume><issue>3</issue><fpage>III</fpage><lpage>VII</lpage><pub-id pub-id-type="doi">10.1590/s0102-76382008000300002</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagni</surname><given-names>S</given-names></name><name><surname>Ulfe</surname><given-names>EA</given-names></name><name><surname>Montgomery</surname><given-names>WD</given-names></name><name><surname>VanHimbergen</surname><given-names>DJ</given-names></name><name><surname>Fisher</surname><given-names>DJ</given-names></name><name><surname>Spence</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Clinical experience with the video-assisted saphenectomy
procedure for coronary bypass operations</article-title><source>Ann Thorac Surg</source><year>1998</year><volume>66</volume><issue>5</issue><fpage>1626</fpage><lpage>1631</lpage><pub-id pub-id-type="doi">10.1016/s0003-4975(98)00783-8</pub-id><pub-id pub-id-type="pmid">9875762</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belczak</surname><given-names>CE</given-names></name><name><surname>Tyszka</surname><given-names>AL</given-names></name><name><surname>Godoy</surname><given-names>JM</given-names></name><name><surname>Ramos</surname><given-names>RN</given-names></name><name><surname>Belczak</surname><given-names>SQ</given-names></name><name><surname>Caffaro</surname><given-names>RA</given-names></name></person-group><article-title>Clinical complications of limb undergone harvesting of great
saphenous vein for coronary artery bypass grafting using bridge
technique</article-title><source>Rev Bras Cir Cardiovasc</source><year>2009</year><volume>24</volume><issue>1</issue><fpage>68</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1590/s0102-76382009000100013</pub-id><pub-id pub-id-type="pmid">19504022</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Song</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>Bilayered negative-pressure wound therapy preventing leg incision
morbidity in coronary artery bypass graft patients: a randomized controlled
trial</article-title><source>Medicine (Baltimore)</source><year>2017</year><volume>96</volume><issue>3</issue><elocation-id>e5925</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000005925</pub-id><pub-id pub-id-type="pmid">28099357</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lommerud</surname><given-names>S</given-names></name><name><surname>Hofoss</surname><given-names>D</given-names></name></person-group><article-title>Leg wound infection after coronary artery bypass grafting: a
natural experiment comparing use and non-use of a compression
stocking</article-title><source>Eur J Cardiovasc Nurs</source><year>2017</year><volume>16</volume><issue>2</issue><fpage>136</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1177/1474515116641298</pub-id><pub-id pub-id-type="pmid">27036953</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLaria</surname><given-names>GA</given-names></name><name><surname>Hunter</surname><given-names>JA</given-names></name><name><surname>Goldin</surname><given-names>MD</given-names></name><name><surname>Serry</surname><given-names>C</given-names></name><name><surname>Javid</surname><given-names>H</given-names></name><name><surname>Najafi</surname><given-names>H</given-names></name></person-group><article-title>Leg wound complications associated with coronary
revascularization</article-title><source>J Thorac Cardiovasc Surg</source><year>1981</year><volume>81</volume><issue>3</issue><fpage>403</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">7464203</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>MA</given-names></name><name><surname>Sundt</surname><given-names>TM</given-names></name><name><surname>Lawton</surname><given-names>JS</given-names></name><name><surname>Damiano</surname><given-names>RJ Jr</given-names></name><name><surname>Hopkins-Broyles</surname><given-names>D</given-names></name><name><surname>Lock-Buckley</surname><given-names>P</given-names></name><etal/></person-group><article-title>Risk factors for leg harvest surgical site infections after
coronary artery bypass graft surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>2003</year><volume>126</volume><issue>4</issue><fpage>992</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1016/S0022-5223(03)00200-9</pub-id><pub-id pub-id-type="pmid">14566237</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>NJ</given-names></name><name><surname>Villavaso</surname><given-names>CD</given-names></name></person-group><article-title>An interprofessional team approach to decreasing surgical site
infection after coronary artery bypass graft surgery</article-title><source>Crit Care Nurs Clin North Am</source><year>2017</year><volume>29</volume><issue>1</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.cnc.2016.09.001</pub-id><pub-id pub-id-type="pmid">28160951</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masini</surname><given-names>BD</given-names></name><name><surname>Stinner</surname><given-names>DJ</given-names></name><name><surname>Waterman</surname><given-names>SM</given-names></name><name><surname>Wenke</surname><given-names>JC</given-names></name></person-group><article-title>Bacterial adherence to suture materials</article-title><source>J Surg Educ</source><year>2011</year><volume>68</volume><issue>2</issue><fpage>101</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1016/j.jsurg.2010.09.015</pub-id><pub-id pub-id-type="pmid">21338964</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurry</surname><given-names>LM</given-names></name><name><surname>Oethinger</surname><given-names>M</given-names></name><name><surname>Levy</surname><given-names>SB</given-names></name></person-group><article-title>Triclosan targets lipid synthesis</article-title><source>Nature</source><year>1998</year><volume>394</volume><issue>6693</issue><fpage>531</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1038/28970</pub-id><pub-id pub-id-type="pmid">9707111</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thimour-Bergstr&#x000f6;m</surname><given-names>L</given-names></name><name><surname>Roman-Emanuel</surname><given-names>C</given-names></name><name><surname>Schersten</surname><given-names>H</given-names></name><name><surname>Frieberg</surname><given-names>O</given-names></name><name><surname>Gudbjartsson</surname><given-names>T</given-names></name><name><surname>Jeppsson</surname><given-names>A</given-names></name></person-group><article-title>Triclosan-coated sutures reduce surgical site infection after
open vein bypass grafting patients: a randomized controlled
trial</article-title><source>Eur J Cardiothorac Surg</source><year>2013</year><volume>44</volume><issue>5</issue><fpage>931</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1093/ejcts/ezt063</pub-id><pub-id pub-id-type="pmid">23435526</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seim</surname><given-names>BE</given-names></name><name><surname>T&#x000f8;nnessen</surname><given-names>T</given-names></name><name><surname>Woldbaek</surname><given-names>PR</given-names></name></person-group><article-title>Triclosan-coated sutures do not reduce leg wound infections after
coronary artery bypass grafting</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2012</year><volume>15</volume><issue>3</issue><fpage>411</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1093/icvts/ivs266</pub-id><pub-id pub-id-type="pmid">22691378</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="book"><source>The R Project for Statistical Computing</source><comment>[Internet]</comment><publisher-loc>Vienna (AU)</publisher-loc><publisher-name>Foundation for Statistical Computing</publisher-name><date-in-citation content-type="access-date">2019 Ago 23</date-in-citation><comment>Available from <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></comment></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname><given-names>HR</given-names></name><name><surname>Jones</surname><given-names>P</given-names></name><name><surname>Gaines</surname><given-names>B</given-names></name><name><surname>Reblock</surname><given-names>K</given-names></name><name><surname>Simpkins</surname><given-names>DL</given-names></name></person-group><article-title>Intraoperative handling and wound healing: controlled clinical
trial comparing coated vicryl&#x000ae; plus antibacterial suture (coated
polyglactin 910 suture with triclosan) with coated vicryl&#x000ae; suture
(coated polyglactin 910 suture)</article-title><source>Surg. Infect (Larchmt)</source><year>2005</year><volume>6</volume><issue>3</issue><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1089/sur.2005.6.313</pub-id><pub-id pub-id-type="pmid">16201941</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swenne</surname><given-names>CL</given-names></name><name><surname>Lindholm</surname><given-names>C</given-names></name><name><surname>Borowiec</surname><given-names>J</given-names></name><name><surname>Carlsson</surname><given-names>M</given-names></name></person-group><article-title>Surgical-site infections within 60 days of coronary artery bypass
graft surgery</article-title><source>J Hosp Infect</source><year>2004</year><volume>57</volume><issue>1</issue><fpage>14</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2004.02.005</pub-id><pub-id pub-id-type="pmid">15142711</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>CA</given-names></name><name><surname>Oliveira</surname><given-names>MA</given-names></name><name><surname>Brandi</surname><given-names>AC</given-names></name><name><surname>Botelho</surname><given-names>PH</given-names></name><name><surname>Brandi Jde</surname><given-names>C</given-names></name><name><surname>Santos</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Risk factors for mortality of patients undergoing coronary artery
bypass graft surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2014</year><volume>29</volume><issue>4</issue><fpage>513</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.5935/1678-9741.20140073</pub-id><pub-id pub-id-type="pmid">25714203</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>RI</given-names></name><name><surname>Smith</surname><given-names>MS</given-names></name><name><surname>Rocker</surname><given-names>G</given-names></name></person-group><article-title>The systemic inflammatory response to cardiopulmonary bypass:
pathophysiological, therapeutic, and pharmacological
considerations</article-title><source>Anesth Analg</source><year>1997</year><volume>85</volume><issue>4</issue><fpage>766</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1097/00000539-199710000-00011</pub-id><pub-id pub-id-type="pmid">9322454</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname><given-names>VG Jr</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>SM</given-names></name><name><surname>Muhlbaier</surname><given-names>LH</given-names></name><name><surname>Corey</surname><given-names>GR</given-names></name><name><surname>Ferguson</surname><given-names>TB</given-names></name><name><surname>Peterson</surname><given-names>ED</given-names></name></person-group><article-title>Clinical predictors of major infections after cardiac
surgery</article-title><source>Circulation</source><year>2005</year><volume>112</volume><issue>9 Suppl</issue><fpage>I358</fpage><lpage>I365</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.104.525790</pub-id><pub-id pub-id-type="pmid">16159846</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jonge</surname><given-names>SW</given-names></name><name><surname>Atema</surname><given-names>JJ</given-names></name><name><surname>Solomkin</surname><given-names>JS</given-names></name><name><surname>Boermeester</surname><given-names>MA</given-names></name></person-group><article-title>Meta-analysis and trial sequential analysis of triclosan-coated
sutures for the prevention of surgical-site infection</article-title><source>Br J Surg</source><year>2017</year><volume>104</volume><issue>2</issue><fpage>e118</fpage><lpage>e133</lpage><pub-id pub-id-type="doi">10.1002/bjs.10445</pub-id><pub-id pub-id-type="pmid">28093723</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Kubilay</surname><given-names>NZ</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Allegranzi</surname><given-names>B</given-names></name><name><surname>Bischoff</surname><given-names>P</given-names></name><name><surname>Zayed</surname><given-names>B</given-names></name><etal/></person-group><article-title>Antimicrobial-coated sutures to decrease surgical site
infections: a systematic review and meta-analysis</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2017</year><volume>36</volume><issue>1</issue><fpage>19</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1007/s10096-016-2765-y</pub-id><comment>Erratum in: Eur J Clin Microbiol Infect Dis.
2018;37(10):2031-4.</comment><pub-id pub-id-type="pmid">27590620</pub-id></element-citation></ref></ref-list></back></article>